TCTP’s implications in pathophysiological conditions in the human brain was first reported by Kim et al. [7], specifically that significantly decreased TCTP expression was observed in the temporal cortices of patients with Alzheimer’s disease and Down’s syndrome. The gene discussed is TPT1; the disease is early-onset autosomal dominant Alzheimer disease.